Association Between Postoperatively Developed Atrial Fibrillation and Long-Term Mortality After Esophagectomy in Esophageal Cancer Patients: An Observational Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 May 6

PMID 27148877

Citations 19

Authors

Ji-Hyun Chin

Young-Jin Moon

Jun-Young Jo

Yun A Han

Hyeong Ryul Kim

Eun-Ho Lee

In-Cheol Choi

Affiliations

Soon will be listed here.

Abstract

Background: Newly developed atrial fibrillation (AF) in patients who have undergone an esophagectomy increases the incidence of postoperative complications. However, the clinical implications of AF have not been fully elucidated in these patients. This retrospective observational study investigated the predictors for AF and the effect of AF on the mortality in esophageal cancer patients undergoing esophagectomy.

Methods: This study evaluated 583 patients undergoing esophagectomy, from January 2005 to April 2012. AF was defined as newly developed postoperative AF requiring treatment. The risk factors for AF and the association between AF and mortality were evaluated. The long-term mortality was the all-cause mortality, for which the cutoff date was May 31, 2014.

Results: AF developed in 63 patients (10.8%). Advanced age (odds ratio [OR] 1.099, 95% confidence interval [CI] 1.056-1.144, P < 0.001), preoperative calcium channel blocker (CCB) (OR 2.339, 95% CI 1.143-4.786, P = 0.020), and angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) (OR 0.206, 95% CI 0.067-0.635, P = 0.006) were associated with the incidence of AF. The Kaplan-Meier curve showed a significantly lower survival rate in the AF group compared to the non-AF group (P = 0.045), during a median follow-up of 50.7 months. The multivariable analysis revealed associations between AF and the 1-year mortality (hazard ratio [HR] 2.556, 95% CI 1.430-4.570, P = 0.002) and between AF and the long-term mortality (HR 1.507, 95% CI 1.003-2.266, P = 0.049).

Conclusions: In esophageal cancer patients, the advanced age and the preoperative medications (CCB, ACEI or ARB) were associated with the incidence of AF. Furthermore, postoperatively developed AF was associated with mortality in esophageal cancer patients after esophagectomy, suggesting that a close surveillance might be required in patients who showed AF during postoperative period.

Citing Articles

Cardiology involvement and mortality in adult patients with advanced solid cancer complicated by atrial fibrillation.

Sato T, Dai Z, Hashimoto J, Ohde S, Komiyama N, Inomata T PLoS One. 2025; 20(2):e0319342.

PMID: 39999078 PMC: 11856317. DOI: 10.1371/journal.pone.0319342.

Neoadjuvant Concurrent Chemoradiation and Esophagectomy for Esophageal Cancer: Outcomes With New-Onset Atrial Fibrillation.

Byer S, Sivamurugan A, Grewal U Thorac Cancer. 2025; 16(1):e15518.

PMID: 39788889 PMC: 11726696. DOI: 10.1111/1759-7714.15518.

Incidence of atrial fibrillation after esophageal cancer surgery with L-carnitine use: a preliminary single-group interventional study.

Shingu Y, Yokota I, Shichinohe T, Murakami S, Ebihara Y, Kurashima Y Surg Today. 2024; 54(8):892-898.

PMID: 38388906 DOI: 10.1007/s00595-024-02802-4.

Risk Factors for Chronic Atrial Fibrillation Development After Esophagectomy for Esophageal Cancer.

Kashiwagi M, Ojima T, Hayata K, Kitadani J, Takeuchi A, Kuroi A J Gastrointest Surg. 2022; 26(12):2451-2459.

PMID: 36271198 DOI: 10.1007/s11605-022-05493-9.

Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHADSVASC score: CCHADSVASC score.

Bungo B, Chaudhury P, Arustamyan M, Rikhi R, Hussain M, Collier P Int J Cardiol Heart Vasc. 2022; 41:101072.

PMID: 35757148 PMC: 9218829. DOI: 10.1016/j.ijcha.2022.101072.

References

Bhayani N, Gupta A, Dunst C, Kurian A, Reavis K, Swanstrom L . Esophagectomies with thoracic incisions carry increased pulmonary morbidity. JAMA Surg. 2013; 148(8):733-8. DOI: 10.1001/jamasurg.2013.2356. View

Law S, Fok M, Wong J . Risk analysis in resection of squamous cell carcinoma of the esophagus. World J Surg. 1994; 18(3):339-46. DOI: 10.1007/BF00316812. View

Bartels H, Stein H, Siewert J . Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg. 1998; 85(6):840-4. DOI: 10.1046/j.1365-2168.1998.00663.x. View

Rao V, Addae-Boateng E, Barua A, Martin-Ucar A, Duffy J . Age and neo-adjuvant chemotherapy increase the risk of atrial fibrillation following oesophagectomy. Eur J Cardiothorac Surg. 2012; 42(3):438-43. DOI: 10.1093/ejcts/ezs085. View

Mehta R, Kellum J, Shah S, Molitoris B, Ronco C, Warnock D . Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11(2):R31. PMC: 2206446. DOI: 10.1186/cc5713. View

von Lewinski D, Kockskamper J, Rubertus S, Zhu D, Schmitto J, Schondube F . Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1 receptor blockade in human atrial myocardium. Eur J Heart Fail. 2008; 10(12):1172-6. DOI: 10.1016/j.ejheart.2008.09.014. View

Blencowe N, Strong S, McNair A, Brookes S, Crosby T, Griffin S . Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg. 2012; 255(4):658-66. DOI: 10.1097/SLA.0b013e3182480a6a. View

Cormack O, Zaborowski A, King S, Healy L, Daly C, OFarrell N . New-onset atrial fibrillation post-surgery for esophageal and junctional cancer: incidence, management, and impact on short- and long-term outcomes. Ann Surg. 2014; 260(5):772-8. DOI: 10.1097/SLA.0000000000000960. View

SHORT D . The syndrome of alternating bradycardia and tachycardia. Br Heart J. 1954; 16(2):208-14. PMC: 479517. DOI: 10.1136/hrt.16.2.208. View

10.

Cardinale D, Colombo A, Sandri M, Lamantia G, Colombo N, Civelli M . Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation. 2007; 115(11):1339-44. DOI: 10.1161/CIRCULATIONAHA.106.647008. View

11.

Ostenfeld E, Erichsen R, Pedersen L, Farkas D, Weiss N, Sorensen H . Atrial fibrillation as a marker of occult cancer. PLoS One. 2014; 9(8):e102861. PMC: 4138009. DOI: 10.1371/journal.pone.0102861. View

12.

Allessie M, Boyden P, Camm A, Kleber A, Lab M, Legato M . Pathophysiology and prevention of atrial fibrillation. Circulation. 2001; 103(5):769-77. DOI: 10.1161/01.cir.103.5.769. View

13.

Stawicki S, Prosciak M, Gerlach A, Bloomston M, Davido H, Lindsey D . Atrial fibrillation after esophagectomy: an indicator of postoperative morbidity. Gen Thorac Cardiovasc Surg. 2011; 59(6):399-405. PMC: 4069196. DOI: 10.1007/s11748-010-0713-9. View

14.

Ma J, Wang Y, Zhao Y, Wu Z, Liu L, Kou Y . Atrial fibrillation after surgery for esophageal carcinoma: clinical and prognostic significance. World J Gastroenterol. 2006; 12(3):449-52. PMC: 4066066. DOI: 10.3748/wjg.v12.i3.449. View

15.

Ojima T, Iwahashi M, Nakamori M, Nakamura M, Katsuda M, Iida T . Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients. Surg Today. 2013; 44(5):839-47. DOI: 10.1007/s00595-013-0616-3. View

16.

Lainscak M, Dagres N, Filippatos G, Anker S, Kremastinos D . Atrial fibrillation in chronic non-cardiac disease: where do we stand?. Int J Cardiol. 2008; 128(3):311-5. DOI: 10.1016/j.ijcard.2007.12.078. View

17.

Coussens L, Werb Z . Inflammation and cancer. Nature. 2002; 420(6917):860-7. PMC: 2803035. DOI: 10.1038/nature01322. View

18.

Chen Y, Chen Y, Tai C, Yeh H, Lin C, Chen S . Angiotensin II and angiotensin II receptor blocker modulate the arrhythmogenic activity of pulmonary veins. Br J Pharmacol. 2005; 147(1):12-22. PMC: 1615848. DOI: 10.1038/sj.bjp.0706445. View

19.

Stippel D, Taylan C, Schroder W, Beckurts K, Holscher A . Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy. Dis Esophagus. 2005; 18(4):267-73. DOI: 10.1111/j.1442-2050.2005.00487.x. View

20.

Imperatori A, Mariscalco G, Riganti G, Rotolo N, Conti V, Dominioni L . Atrial fibrillation after pulmonary lobectomy for lung cancer affects long-term survival in a prospective single-center study. J Cardiothorac Surg. 2012; 7:4. PMC: 3287133. DOI: 10.1186/1749-8090-7-4. View